1 – 250 of 376
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Increased risk of venous thromboembolism in young and middle-aged individuals with hereditary angioedema : a family study
2024) In Blood(
- Contribution to journal › Article
-
Mark
Vector integration and fate in the hemophilia dog liver multi-years following AAV-FVIII gene transfer
2024) In Blood(
- Contribution to journal › Article
- 2021
-
Mark
Genomic and transcriptomic correlates of Richter's transformation in Chronic Lymphocytic Leukemia
(
- Contribution to journal › Article
-
Mark
Platelet EVs contain an active proteasome involved in protein processing for antigen presentation via MHC-I molecules
(
- Contribution to journal › Article
- 2020
-
Mark
Quantitative proteomics reveals specific metabolic features of Acute Myeloid Leukemia stem cells
(
- Contribution to journal › Article
-
Mark
Lysine-specific demethylase 1A (LSD1) restricts ex vivo propagation of human HSCs and is a target of UM171
(
- Contribution to journal › Article
-
Mark
Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL
(
- Contribution to journal › Letter
-
Mark
A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
2020) In Blood(
- Contribution to journal › Article
-
Mark
Is the CNS-PINK the new CNS risk model in ENKTL?
(
- Contribution to journal › Article
- 2019
-
Mark
Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk
(
- Contribution to journal › Article
-
Mark
Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A
(
- Contribution to journal › Letter
-
Mark
Osteopontin mediates murine transfusion-related acute lung injury through stimulation of pulmonary neutrophil accumulation.
(
- Contribution to journal › Article
-
Mark
Transfusion-associated circulatory overload and transfusion-related acute lung injury.
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Allele-selective RUNX1 binding regulates P1 blood group status by transcriptional control of A4GALT
(
- Contribution to journal › Article
-
Mark
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma
(
- Contribution to journal › Article
-
Mark
Mouse and human HSPC immobilization in liquid culture by CD43- or CD44-antibody coating
(
- Contribution to journal › Article
-
Mark
Small Molecule Screens Identify CDK8-Inhibitors As Candidate Diamond-Blackfan Anemia Drugs
(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
Near-haploid and low hypodiploid acute lymphoblastic leukemia - two distinct subtypes but consistently poor prognosis
(
- Contribution to journal › Article
-
Mark
Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML
(
- Contribution to journal › Article
-
Mark
Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS and neurological symptoms
(
- Contribution to journal › Article
-
Mark
T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10
(
- Contribution to journal › Article
- 2016
-
Mark
Gas6 fueling tumor-mediated thrombosis.
(
- Contribution to journal › Article
-
Mark
Diverse roles of cell-specific hypoxia-inducible factor 1 in cancer-associated hypercoagulation.
(
- Contribution to journal › Article
-
Mark
PET-CT for staging & early response: results from 'Response Adapted Therapy in Advanced Hodgkin Lymphoma' (RATHL) (CRUK/07/033).
(
- Contribution to journal › Article
-
Mark
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
(
- Contribution to journal › Article
-
Mark
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.
(
- Contribution to journal › Article
-
Mark
Lenalidomide-bendamustine-rituximab in untreated mantle cell lymphoma > 65 years, the Nordic Lymphoma Group phase I+II trial NLG-MCL4
(
- Contribution to journal › Article
-
Mark
Move over Tregs, MDSCs are here
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia
(
- Contribution to journal › Article
-
Mark
IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
(
- Contribution to journal › Article
-
Mark
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease : a multicenter experience
(
- Contribution to journal › Article
-
Mark
Expansion and Biased Commitment of Hematopoietic Stem Cells Towards Erythroid Cells upon Acute Anemia Induction
(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Reflections on the FranceCoag report on inhibitory antibodies to factor VIII in patients with severe hemophilia A.
(
- Contribution to journal › Letter
-
Mark
Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival.
(
- Contribution to journal › Letter
-
Mark
Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiency.
(
- Contribution to journal › Article
-
Mark
A novel mechanism for NETosis provides antimicrobial defense at the oral mucosa.
(
- Contribution to journal › Article
-
Mark
miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.
(
- Contribution to journal › Article
-
Mark
Can a "center effect" explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?
(
- Contribution to journal › Letter
-
Mark
The first specific antiplatelet antidote.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
FVIII inhibitors: pathogenesis and avoidance.
(
- Contribution to journal › Scientific review
-
Mark
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
(
- Contribution to journal › Article
-
Mark
Risk of familial classical Hodgkin lymphoma by relationship, histology, age, and sex: A joint study from five Nordic countries.
(
- Contribution to journal › Article
-
Mark
Central nervous system relapse in peripheral T-cell lymphomas: A Swedish lymphoma registry study.
(
- Contribution to journal › Article
-
Mark
TGF-β signaling in the control of hematopoietic stem cells.
(
- Contribution to journal › Article
-
Mark
Jarid2 regulates hematopoietic stem cell function by acting with polycomb repressive complex 2.
(
- Contribution to journal › Article
-
Mark
Outcome and risk factor analysis of molecular subgroups in cytogenetically normal AML treated by allogeneic transplantation.
(
- Contribution to journal › Article
-
Mark
C-reactive protein enhances murine antibody-mediated transfusion-related acute lung injury
(
- Contribution to journal › Article
-
Mark
C-reactive protein boosts antibody-mediated platelet destruction
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.
(
- Contribution to journal › Article
-
Mark
HIF-1α can act as a tumor suppressor gene in murine Acute Myeloid Leukemia.
(
- Contribution to journal › Article
-
Mark
Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients
(
- Contribution to journal › Article
-
Mark
Nordic MCL3 study: Y-90-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma
(
- Contribution to journal › Article
-
Mark
Robust isolation of malignant plasma cells in multiple myeloma.
(
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.
(
- Contribution to journal › Article
-
Mark
TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain
(
- Contribution to journal › Article
-
Mark
Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort.
(
- Contribution to journal › Article
-
Mark
Risk of RAS in relapsed childhood ALL.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Inherited genetic susceptibility to monoclonal gammopathy of unknown significance
(
- Contribution to journal › Article
-
Mark
Real world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.
(
- Contribution to journal › Article
-
Mark
Analysis of the DNA methylome and transcriptome in granulopoiesis reveals timed changes and dynamic enhancer methylation
(
- Contribution to journal › Article
-
Mark
KIR B haplotype donors confer a reduced risk of relapse after haploidentical transplantation in children with acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation
(
- Contribution to journal › Article
-
Mark
Peripheral blood monocyte-derived chemokine blockade prevents murine transfusion-related acute lung injury (TRALI)
(
- Contribution to journal › Article
-
Mark
Allogeneic platelet transfusions prevent murine T-cell-mediated immune thrombocytopenia
(
- Contribution to journal › Article
-
Mark
Comparison of MRD monitoring by IG/TR rearrangement and BCR/ABL1 transcript in PH+ pediatric acute lymphoblastic leukemia patients treated with imatinib in the EsPhALL study
(
- Contribution to journal › Published meeting abstract
-
Mark
Comprehensive genetic characterization of pediatric T-cell acute lymphoblastic leukemia
(
- Contribution to journal › Published meeting abstract
-
Mark
IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes
(
- Contribution to journal › Article
- 2013
-
Mark
The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.
(
- Contribution to journal › Article
-
Mark
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry
(
- Contribution to journal › Article
-
Mark
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
(
- Contribution to journal › Article
-
Mark
Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system
(
- Contribution to journal › Article
-
Mark
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
(
- Contribution to journal › Article
-
Mark
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype
(
- Contribution to journal › Article
-
Mark
Identification of the chemokine CCL28 as a growth and survival factor for human hematopoietic stem- and progenitor cells.
(
- Contribution to journal › Article
-
Mark
Non-Hodgkin lymphoma in familial amyloid polyneuropathy patients in Sweden
(
- Contribution to journal › Letter
-
Mark
Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A
(
- Contribution to journal › Article
-
Mark
Interfering with histone demethylases in HSCs.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.
(
- Contribution to journal › Article
-
Mark
Platelets activated during myocardial infarction release functional miRNA which can be taken up by endothelial cells and regulate ICAM1 expression.
(
- Contribution to journal › Article
-
Mark
An epigenetic component of hematopoietic stem cell aging amenable to reprogramming into a young state.
(
- Contribution to journal › Article
-
Mark
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
(
- Contribution to journal › Article
-
Mark
Intermediate- dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
(
- Contribution to journal › Article
-
Mark
Platelets deliver small packages of genetic function
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Genetic elimination of the binding motif on fibrinogen for the S. aureus virulence factor ClfA improves host survival in septicemia.
(
- Contribution to journal › Article
-
Mark
A Robust Screening Assay For Diamond Blackfan Anemia Candidate Drugs
(
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
Smad2/Smad3 in endothelium is indispensable for vascular stability via S1PR1 and N-cadherin expressions
(
- Contribution to journal › Article
-
Mark
Second malignancies after multiple myeloma: from 1960s to 2010s
(
- Contribution to journal › Scientific review
-
Mark
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Emergence of NK cell progenitors and functionally competent NK cell lineage subsets in the early mouse embryo.
(
- Contribution to journal › Article
-
Mark
Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004
(
- Contribution to journal › Article
-
Mark
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
(
- Contribution to journal › Article
-
Mark
High ERG gene expression is an unfavorable prognostic marker in pediatric acute myeloid leukemia Response
(
- Contribution to journal › Letter
-
Mark
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
(
- Contribution to journal › Article
-
Mark
Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis
(
- Contribution to journal › Article
-
Mark
DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues
(
- Contribution to journal › Article
-
Mark
Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3
(
- Contribution to journal › Article
-
Mark
SRC is a signaling mediator in FLT3-ITD-but not in FLT3-TKD-positive AML
(
- Contribution to journal › Article
-
Mark
HemaExplorer: a Web server for easy and fast visualization of gene expression in normal and malignant hematopoiesis
(
- Contribution to journal › Letter
-
Mark
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
(
- Contribution to journal › Article
-
Mark
RNAi screen identifies MAPK14 as a druggable suppressor of human hematopoietic stem cell expansion.
(
- Contribution to journal › Article
-
Mark
Human hematopoietic stem/progenitor cells overexpressing Smad4 exhibit impaired reconstitution potential in vivo.
(
- Contribution to journal › Article
-
Mark
Acute myeloid leukemia in the real world: why population-based registries are needed.
(
- Contribution to journal › Article
-
Mark
Do HSCs divide asymmetrically?
(
- Contribution to journal › Article
-
Mark
Dietary L-leucine improves the anemia in a mouse model for Diamond-Blackfan anemia.
(
- Contribution to journal › Article
-
Mark
Bregging rights in ITP
(
- Contribution to journal › Scientific review
-
Mark
Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia
(
- Contribution to journal › Article
- 2011
-
Mark
Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense.
(
- Contribution to journal › Article
-
Mark
Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B
(
- Contribution to journal › Article
-
Mark
Stress hematopoiesis requires Erg
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization
(
- Contribution to journal › Article
-
Mark
FLT3 expression initiates in fully multipotent mouse hematopoietic progenitor cells
(
- Contribution to journal › Article
-
Mark
Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials
(
- Contribution to journal › Article
-
Mark
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide
(
- Contribution to journal › Article
-
Mark
Combination of pegylated IFN-alpha 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment.
(
- Contribution to journal › Letter
-
Mark
beta(2)-Glycoprotein I: a novel component of innate immunity
(
- Contribution to journal › Article
-
Mark
Hypoxic induction of vascular endothelial growth factor regulates murine hematopoietic stem cell function in the low-oxygenic niche.
(
- Contribution to journal › Article
-
Mark
Identification of a novel A4GALT exon reveals the genetic basis of the P1/P2 histo-blood groups.
(
- Contribution to journal › Article
-
Mark
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
(
- Contribution to journal › Article
-
Mark
From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications
(
- Contribution to journal › Scientific review
-
Mark
Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation
(
- Contribution to journal › Article
-
Mark
IL-7 mediates Ebf-1-dependent lineage restriction in early lymphoid progenitors
(
- Contribution to journal › Article
-
Mark
Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party
(
- Contribution to journal › Article
-
Mark
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)
(
- Contribution to journal › Article
-
Mark
Activated protein C cofactor function of protein S: a novel role for a gamma-carboxyglutamic acid residue
(
- Contribution to journal › Article
-
Mark
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
(
- Contribution to journal › Article
-
Mark
Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study
(
- Contribution to journal › Article
-
Mark
Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
Joining the stem cell maintenance squad.
(
- Contribution to journal › Article
-
Mark
Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia.
(
- Contribution to journal › Article
-
Mark
Erythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment
(
- Contribution to journal › Article
-
Mark
SMAD4 binds HOXA9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by HOXA9 and leukemia transformation.
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of imatinib on top of BFM-like chemotherapy in pediatric patients with Ph+/BCR-ABL+ acute lymphoblastic leukemia (Ph+ALL). the EsPhALL study
(
- Contribution to journal › Published meeting abstract
-
Mark
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)
(
- Contribution to journal › Article
- 2010
-
Mark
Regular Replacement Therapy as Prophylaxis In Severe Forms of Von Willebrand Disease Initial Results From the Von Willebrand Disease Prophylaxis Network (VWD PN) Study Group
(
- Contribution to journal › Published meeting abstract
-
Mark
Chronic RPS19 Deficiency Leads to Bone Marrow Failure In a Mouse Model for Diamond Blackfan Anemia
(
- Contribution to journal › Published meeting abstract
-
Mark
The Role of the Rituximab Partner Chemotherapy Regimen In Young Patients with Good Prognosis Diffuse Large B Cell Lymphoma (DLBCL) Results of the 6 Year Follow up of the Mint Study of the Mabthera International Trial (Mint) Group
(
- Contribution to journal › Published meeting abstract
-
Mark
R CHOEP 14 x 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B Cell Lymphoma/Follicular Lymphoma Grade 3 with Age Adjusted IPI Score 2-3 Final Results of a Nordic Lymphoma Group Phase 2 Study Including 156 Patients Aged 18-65 Years
(
- Contribution to journal › Published meeting abstract
-
Mark
Favorable Outcome In ALK Negative Anaplastic Large Cell Lymphoma Following Intensive Induction Chemotherapy and Autologous Stem Cell Transplantation (ASCT) a Prospective Study by the Nordic Lymphoma Group (NLG T 01)
(
- Contribution to journal › Published meeting abstract
-
Mark
Endothelial protein C receptor-expressing hematopoietic stem cells reside in the perisinusoidal niche in fetal liver
(
- Contribution to journal › Article
-
Mark
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
(
- Contribution to journal › Article
-
Mark
Genome Wide Array Based Methylation Profiling Reveals Preferential Methylation of Homeobox Transcription Factor Genes In Mantle Cell Lymphoma and Pro Apoptotic Genes In Chronic Lymphocytic Leukemia
(
- Contribution to journal › Published meeting abstract
-
Mark
Cripto Selectively Expands a Distinct Population of Hematopoietic Stem Cells Expressing the Cell Surface Receptor GRP78 and Strongly Induces An Immature Phenotype In Vivo After Ex Vivo Culture
(
- Contribution to journal › Published meeting abstract
-
Mark
Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study
(
- Contribution to journal › Published meeting abstract
-
Mark
Human Embryonic Stem Cell Derived Mesenchymal Stroma Cells (hES-MSC) Share Basic Properties with Bone Marrow MSC, They Have Potent Stroma Support Capacities but Lack Immune Modulatory Function Implications for off the Shelf ES MSC Therapies
(
- Contribution to journal › Published meeting abstract
-
Mark
Selective Persistence of Distinct Stem/B Leukaemic Stem Cells In Childhood Acute Lymphoblastic Leukaemia In Clinical Remission
(
- Contribution to journal › Published meeting abstract
-
Mark
beta(2)-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome
(
- Contribution to journal › Article
-
Mark
Single cell analysis of the common lymphoid progenitor compartment reveals functional and molecular heterogeneity.
(
- Contribution to journal › Article
-
Mark
Myeloid Leukemia of Down Syndrome The Results of An International Retrospective Study
(
- Contribution to journal › Published meeting abstract
-
Mark
Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain
(
- Contribution to journal › Article
-
Mark
The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)
(
- Contribution to journal › Article
-
Mark
Inhibitor Eradication In Acquired Haemophilia A Final Results of European Acquired Haemophilia Registry (EACH2)
(
- Contribution to journal › Published meeting abstract
-
Mark
W41/W41 blastocyst complementation: a system for genetic modeling of hematopoiesis.
(
- Contribution to journal › Article
-
Mark
Monoclonal Gammopathy of Undetermined Significance and Risk of Infections A Population Based Study
(
- Contribution to journal › Published meeting abstract
-
Mark
The IgG specific endoglycosidase EndoS inhibits both cellular and complement mediated autoimmune hemolysis.
(
- Contribution to journal › Article
-
Mark
A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy
(
- Contribution to journal › Article
-
Mark
High Levels of the Adhesion Molecule CD44 on Leukemic Cells Generate Acute Myeloid Leukemia Relapse After Withdrawal of the Initial Transforming Event
(
- Contribution to journal › Published meeting abstract
-
Mark
The Success Story of Targeted Therapy In Chronic Myeloid Leukemia A Population Based Study of 3,173 Patients Diagnosed In Sweden 1973-2008
(
- Contribution to journal › Published meeting abstract
-
Mark
Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy
(
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study
(
- Contribution to journal › Article
-
Mark
Prophylactic Dosing of Anti Inhibitor Coagulant Complex (FEIBA) Reduces Bleeding Frequency In Hemophilia A Patients with Inhibitors Results of the Pro FEIBA Study
(
- Contribution to journal › Published meeting abstract
-
Mark
High Serum Vascular Endothelial Growth Factor (VEGF) Level Is An Adverse Prognostic Factor In High Risk Diffuse Large B Cell Lymphoma (DLBCL) Patients Treated with Dose Dense Chemoimmunotherapy and Systemic CNS Prophylaxis Results From a Nordic Phase II Study
(
- Contribution to journal › Published meeting abstract
-
Mark
Acquired Haemophilia Clinical and Demographic Data Results of European Acquired Haemophilia Registry (EACH2)
(
- Contribution to journal › Published meeting abstract
-
Mark
Management of Bleeding In Acquired Hemophilia Results of the European Acquired Hemophilia Registry (EACH2)
(
- Contribution to journal › Published meeting abstract
-
Mark
Acquired Haemophilia A and Pregnancy/Postpartum - a Report From a European Registry
(
- Contribution to journal › Published meeting abstract
-
Mark
Unrelated Clones In Myelodysplastic Syndromes and Acute Myeloid Leukemia Characterization and Prognostic Relevance
(
- Contribution to journal › Published meeting abstract
-
Mark
CNS Disease In Younger Patients (
(
- Contribution to journal › Published meeting abstract
-
Mark
90Yttrium Ibritumomab Tiuxetan as First Line Treatment for Follicular Lymphoma First Results from an International Phase II Clinical Trial
(
- Contribution to journal › Published meeting abstract
-
Mark
Intensive Induction Chemotherapy Followed by Autologous Stem Cell Transplantation (ASCT) In Patients with Enteropathy Associated T Cell Lymphoma a Prospective Study by the Nordic Lymphoma Group (NLG T 01)
(
- Contribution to journal › Published meeting abstract
-
Mark
Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice
(
- Contribution to journal › Article
-
Mark
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
(
- Contribution to journal › Article
-
Mark
Identification of a NK/T cell restricted progenitor in adult bone marrow contributing to bone marrow and thymic-dependent NK cells.
(
- Contribution to journal › Article
-
Mark
SMAD4 Sequestrates HOXA9 to Protect Hematopoietic Stem Cells Against Leukemia Transformation
(
- Contribution to journal › Published meeting abstract
-
Mark
Safety of Recombinant Human Factor IX, Nonacog Alfa, for Usual Use In Pediatric Patients Results From a Prospective Registry of European Hemophilia B Patients
(
- Contribution to journal › Published meeting abstract
-
Mark
A Novel Immunohistochemical Sequential Multi Labelling and Erasing Technique Enables Epitope Characterization of Bone Marrow Pericytes In Primary Myelofibrosis
(
- Contribution to journal › Published meeting abstract
-
Mark
Population-based analyses in adult acute lymphoblastic leukemia
(
- Contribution to journal › Letter
-
Mark
The Proportion of Ph+CD34(+)CD38(neg) Leukemic Stem Cells In the Bone Marrow of Newly Diagnosed Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Is Variable and Correlates with High Sokal Risk, High Leukocyte Count, Low Hemoglobin Concentration, Splenomegaly and Increased Hematological Toxicity During Initial TKI Therapy Data From a Randomized Phase II NordCML006 Study
(
- Contribution to journal › Published meeting abstract
-
Mark
Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development.
(
- Contribution to journal › Article
-
Mark
Histidine-rich glycoprotein promotes bacterial entrapment in clots and decreases mortality in a mouse model of sepsis.
(
- Contribution to journal › Article
-
Mark
Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.
(
- Contribution to journal › Article
-
Mark
Different molecular behavior of CD40 mutants causing hyper-IgM syndrome.
(
- Contribution to journal › Article
-
Mark
Canonical BMP signaling is dispensable for hematopoietic stem cell function in both adult and fetal liver hematopoiesis, but essential to preserve colon architecture.
(
- Contribution to journal › Article
-
Mark
Epigenetic chromatin states uniquely define the developmental plasticity of murine hematopoietic stem cells.
(
- Contribution to journal › Article
-
Mark
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA.
(
- Contribution to journal › Article
-
Mark
Recipient T lymphocytes modulate the severity of antibody-mediated transfusion-related acute lung injury
(
- Contribution to journal › Article
-
Mark
A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy
(
- Contribution to journal › Article
-
Mark
Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood
(
- Contribution to journal › Article
- 2009
-
Mark
Long-Term Follow-up of HCV Infected Stem Cell Transplant Patients and Effects of Antiviral Therapy.
(
- Contribution to journal › Published meeting abstract
-
Mark
The human P-k histo-blood group antigen provides protection against HIV-1 infection
(
- Contribution to journal › Article
-
Mark
Lenalidomide in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia with Chromosome 5 Abnormalities
(
- Contribution to journal › Published meeting abstract
-
Mark
Bio-Distribution of Recombinant Factor VIIa: A Possible Explanation for the Hemostatic Effect of rFVIIa in Prophylaxis
(
- Contribution to journal › Published meeting abstract
-
Mark
Forward RNAi screens in primary human hematopoietic stem/progenitor cells
(
- Contribution to journal › Article
-
Mark
Large Granular Lymphocyte (LGL) Expansions Comprising Oligoclonal T Cell or NK Cell Populations in Dasatinib Treated Patients Are Associated with HLA-A*0201, CMV Reactivation and Enhanced Anti-Leukemic Control.
(
- Contribution to journal › Published meeting abstract
-
Mark
Incidence of Veno-Occlusive Disease with IV in Busulfan Children Is Higher Than Expected: Preliminary Results of the VOD-DF Trial
(
- Contribution to journal › Published meeting abstract
-
Mark
A Novel Mouse Model for RPS19-Deficient Diamond-Blackfan Anemia Locates the Erythroid Defect at CFU-E/Proerythroblast Transition
(
- Contribution to journal › Published meeting abstract
-
Mark
Proportion of Adult AML Patient Population Receiving Allogeneic Stem Cell Transplantation and Long-Term Outcome: Real World Data From the Swedish National Acute Leukemia Registry.
(
- Contribution to journal › Published meeting abstract
-
Mark
CD146 Expression in Primary Bone Marrow MSC Progenitor/Stem Cells Is Dependent On Their In Vivo Location
(
- Contribution to journal › Published meeting abstract
-
Mark
Genetic Factors Associated with Inhibitor Development in Hemophilia A: Initial Results From the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of a Novel Aberrant Splice Site, 79bp Downstream of Exon 5 in the Human Factor 7 Gene Detected in Patients with Severe Congenital Factor VII Deficiency.
(
- Contribution to journal › Published meeting abstract
-
Mark
Impact of FISH and Cytogenetics On Overall and Event Free Survival in Myeloma: An IMWG Analysis of 9,897 Patients
(
- Contribution to journal › Published meeting abstract
-
Mark
Treatment of invasive streptococcal infection with a peptide derived from human high molecular weight kininogen.
(
- Contribution to journal › Article
-
Mark
FLT3 receptor and ligand are dispensable for maintenance and posttransplantation expansion of mouse hematopoietic stem cells
(
- Contribution to journal › Article
-
Mark
Risk of plasma cell and lymphoproliferative disorders among 14 621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden
(
- Contribution to journal › Article
-
Mark
In Infant ALL with t(4;11)/MLL-AF4 Multiple and Phenotypically Distinct CD19+BM Subsets Initiate Leukemia in NOD/SCID Mice
(
- Contribution to journal › Published meeting abstract
-
Mark
Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse
(
- Contribution to journal › Published meeting abstract
-
Mark
Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial
(
- Contribution to journal › Published meeting abstract
-
Mark
Relapsed Childhood High Hyperdiploid Acute Lymphoblastic Leukemia: Genome-Wide Screening Reveals the Presence of Preleukemic Ancestral Clones and the Secondary Nature of Microdeletions and RTK-RAS Mutations
(
- Contribution to journal › Published meeting abstract
-
Mark
A novel molecular mechanism of primary resistance to FLT3-kinase inhibitors in AML
(
- Contribution to journal › Article
-
Mark
(90)y-Ibritumumab Tiuxetan (Zevalin (R))-BEAM/C with Autologous Stem Cell Support as Frontline Therapy for Advanced Mantle Cell Lymphoma.- Preliminary Results From the Third Nordic MCL Phase II Study (MCL3)
(
- Contribution to journal › Published meeting abstract
-
Mark
Mono/Oligoclonal T and NK Cells Are Common in Philadelphia Chromosome Positive (Ph plus ) Leukemia Patients at Diagnosis and Expand During Successful Tyrosine Kinase Inhibitor Therapy
(
- Contribution to journal › Published meeting abstract
-
Mark
High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle
(
- Contribution to journal › Article
-
Mark
Arterial and Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Population-Based Study
(
- Contribution to journal › Published meeting abstract
-
Mark
Polyclonal T-cell reconstitution of X-SCID recipients after in utero transplantation of lymphoid-primed multipotent progenitors
(
- Contribution to journal › Article
-
Mark
Bendamustine in the Treatment of Chronic Lymphocytic Leukemia - Consistent Superiority Over Chlorambucil in Elderly Patients and Across Clinically Defined Risk Groups
(
- Contribution to journal › Published meeting abstract
-
Mark
Toward a stem cell gene therapy for breast cancer
(
- Contribution to journal › Article
-
Mark
LPL Is the Strongest Prognostic Factor in a Comparative Study of RNA-Based Markers in Chronic Lymphocytic Leukemia
(
- Contribution to journal › Published meeting abstract
-
Mark
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.
(
- Contribution to journal › Article
-
Mark
Is TGF-beta a stemness regulator?
(
- Contribution to journal › Article
-
Mark
ITP has elevated BAFF expression
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Processed platelet HPA1a peptides au naturel
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Platelet antigen-induced regulation in ITP
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells
(
- Contribution to journal › Article
-
Mark
Niche Recycling through Division-Independent Egress of Hematopoietic Stem Cells.
(
- Contribution to journal › Published meeting abstract
-
Mark
Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia
(
- Contribution to journal › Article
-
Mark
Naturally occurring short splice variant of CYLD positively regulates dendritic cell function
(
- Contribution to journal › Article
-
Mark
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
(
- Contribution to journal › Article
- 2008
-
Mark
Impaired Function of Hematopoietic Stem Cells with Abrogated Hypoxia Induced Expression of Vascular Endothelial Growth Factor
(
- Contribution to journal › Published meeting abstract
-
Mark
Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference
(
- Contribution to journal › Article
-
Mark
Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes
(
- Contribution to journal › Article
-
Mark
Nuclear expression of the Non-B Cell Lineage Sox11 Transcription Factor Identifies Mantle Cell Lymphoma
(
- Contribution to journal › Article
-
Mark
Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study
(
- Contribution to journal › Article
-
Mark
R-CHOEP-14 X 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2-3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18-64 Years.
(
- Contribution to journal › Published meeting abstract
-
Mark
Clonal Expansion of T/NK-Cells during Tyrosine Kinase Inhibitor Dasatinib Therapy
(
- Contribution to journal › Published meeting abstract
-
Mark
Permissive roles of hematopoietin and cytokine tyrosine kinase receptors in early T cell development
(
- Contribution to journal › Article
-
Mark
Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis
(
- Contribution to journal › Article
-
Mark
B-lineage commitment prior to surface expression of B220 and CD19 on hematopoietic progenitor cells
(
- Contribution to journal › Article
-
Mark
Stabilin-1 and Stabilin-2 Are Expressed in Bone Marrow Sinusoidal Endothelial Cells and Mediate Scavenging and Cell Adhesive Functions
(
- Contribution to journal › Published meeting abstract
-
Mark
Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis
(
- Contribution to journal › Article
-
Mark
Age and Prognosis in Pediatric AML
(
- Contribution to journal › Published meeting abstract
-
Mark
Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy
(
- Contribution to journal › Published meeting abstract
-
Mark
Novel markers of normal and neoplastic human plasmacytoid dendritic cells
(
- Contribution to journal › Scientific review
-
Mark
Patients with Mature T-Cell Lymphoma Show High Relapse Rates after High Dose Therapy and Autologous Stem Cell Transplantation
(
- Contribution to journal › Published meeting abstract
-
Mark
Downregulation of Mpl marks the transition to lymphoid-primed multipotent progenitors with gradual loss of granulocyte-monocyte potential.
(
- Contribution to journal › Article
-
Mark
Biomarkers of Cartilage and Bone Damage as a Measure of Joint Damage in Haemophilia.
(
- Contribution to journal › Published meeting abstract
-
Mark
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
(
- Contribution to journal › Article
-
Mark
Familial Aggregation of Multiple Myeloma and Its Precursor Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study in Sweden
(
- Contribution to journal › Published meeting abstract
-
Mark
Smad4 as a Therapeutic Target in Nup98-HoxA9-Induced Leukemia.
(
- Contribution to journal › Published meeting abstract
-
Mark
Immune-Related and Inflammatory Conditions Likely Play a Role in the Development of Lymphoplasmacytic Lymphoma/Waidenstrom's Macroglobulinemia.
(
- Contribution to journal › Published meeting abstract
-
Mark
Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation
(
- Contribution to journal › Article